Literature DB >> 11959806

Second messenger-dependent protein kinases and protein synthesis regulate endogenous secretin receptor responsiveness.

Roxana S Ghadessy1, Eamonn Kelly.   

Abstract

1. The present study investigated the role of second messenger-dependent protein kinase A (PKA) and C (PKC) in the regulation of endogenous secretin receptor responsiveness in NG108-15 mouse neuroblastomaxrat glioma hybrid cells. 2. In whole cell cyclic AMP accumulation studies, activation of PKC either by phorbol 12-myristate 13-acetate (PMA) or by purinoceptor stimulation using uridine 5'-triphosphate (UTP) decreased secretin receptor responsiveness. PKC activation also inhibited forskolin-stimulated cyclic AMP accumulation but did not affect cyclic AMP responses mediated by the prostanoid-IP receptor agonist iloprost, or the A(2) adenosine receptor agonist 5'-(N-ethylcarboxamido) adenosine (NECA). 3. In additivity experiments, saturating concentrations of secretin and iloprost were found to be additive in terms of cyclic AMP accumulation, whereas saturating concentrations of NECA and iloprost together were not. This suggests compartmentalization of G(s)-coupling components in NG108-15 cells and possible heterologous regulation of secretin receptor responsiveness at the level of adenylyl cyclase activation. 4. Cells exposed to the PKA inhibitor H-89, exhibited a time-dependent increase in secretin receptor responsiveness compared to control cells. This effect was selective since cyclic AMP responses to forskolin, iloprost and NECA were not affected by H-89 treatment. Furthermore, treatment with the protein synthesis inhibitor cycloheximide produced a time-dependent increase in secretin receptor responsiveness. 5. Together these results indicate that endogenous secretin receptor responsiveness is regulated by PKC, PKA and protein neosynthesis in NG108-15 cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11959806      PMCID: PMC1573319          DOI: 10.1038/sj.bjp.0704655

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  Selective reduction in A2 adenosine receptor desensitization following antisense-induced suppression of G protein-coupled receptor kinase 2 expression.

Authors:  J M Willets; J L Parent; J L Benovic; E Kelly
Journal:  J Neurochem       Date:  1999-11       Impact factor: 5.372

Review 2.  Structural, electrophysiological, biochemical, and pharmacological properties of neuroblastoma-glioma cell hybrids in cell culture.

Authors:  B Hamprecht
Journal:  Int Rev Cytol       Date:  1977

3.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

Review 4.  Structure-activity relationships for inhibitors of phosphodiesterase from erythrocytes and other tissues.

Authors:  H Sheppard; G Wiggan; W H Tsien
Journal:  Adv Cyclic Nucleotide Res       Date:  1972

Review 5.  Regulation of transmembrane signaling by receptor phosphorylation.

Authors:  D R Sibley; J L Benovic; M G Caron; R J Lefkowitz
Journal:  Cell       Date:  1987-03-27       Impact factor: 41.582

6.  Hormone-specific combinations of isoforms of adenylyl cyclase and phosphodiesterase in the rat liver.

Authors:  K Yamatani; K Saito; K Takahashi; H Ohnuma; H Manaka; H Sasaki
Journal:  Regul Pept       Date:  2001-05-05

Review 7.  Regulation and role of adenylyl cyclase isoforms.

Authors:  J Hanoune; N Defer
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

8.  The N terminus domain of type VI adenylyl cyclase mediates its inhibition by protein kinase C.

Authors:  H L Lai; T H Lin; Y Y Kao; W J Lin; M J Hwang; Y Chern
Journal:  Mol Pharmacol       Date:  1999-09       Impact factor: 4.436

9.  In-vivo stimulation of rat pancreatic acinar cells by infusion of secretin. I. Changes in enzyme content, pancreatic fine structure and total rate of protein synthesis.

Authors:  U Rausch; P Vasiloudes; K Rüdiger; H F Kern
Journal:  Cell Tissue Res       Date:  1985       Impact factor: 5.249

10.  Secretin: specific binding to rat brain membranes.

Authors:  R T Fremeau; R T Jensen; C G Charlton; R L Miller; T L O'Donohue; T W Moody
Journal:  J Neurosci       Date:  1983-08       Impact factor: 6.167

View more
  3 in total

1.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

2.  PAC1hop, null and hip receptors mediate differential signaling through cyclic AMP and calcium leading to splice variant-specific gene induction in neural cells.

Authors:  Yvonne Holighaus; Tomris Mustafa; Lee E Eiden
Journal:  Peptides       Date:  2011-06-12       Impact factor: 3.750

3.  G protein-coupled receptor kinase 6 (GRK6) selectively regulates endogenous secretin receptor responsiveness in NG108-15 cells.

Authors:  Roxana S Ghadessy; Jonathon M Willets; Eamonn Kelly
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.